U.S. Markets
US appeals court revives private lawsuits linking Tylenol painkiller to Autism and ADHD
StockNow breaking-news AI analysis
A US appeals court revived Tylenol-related autism lawsuits on July 13, 2026, overturning a previous dismissal and significantly increasing legal risks for Kenvue and Johnson & Johnson.
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
